临床肺癌 SCIE

期刊简介估计审稿时候： 较慢,6-12周

Clinical Lung Cancer is a peer-reviewed bimonthly journal that publishes original articles describing various aspects of clinical and translational research of lung cancer. Clinical Lung Cancer is devoted to articles on detection, diagnosis, prevention, and treatment of lung cancer. The main emphasis is on recent scientific developments in all areas related to lung cancer. Specific areas of interest include clinical research and mechanistic approaches; drug sensitivity and resistance; gene and antisense therapy; pathology, markers, and prognostic indicators; chemoprevention strategies; multimodality therapy; and integration of various approaches.

《临床肺癌》是一份同业评审的双月刊，颁发首创文章，先容肺癌临床和转化研讨的各个方面。《临床肺癌》努力于颁发有关肺癌检测、诊断、防备和医治的文章。首要重点是与肺癌相干的一切范畴的最新迷信成长。详细感乐趣的范畴包含临床研讨和机制体例；药物敏理性和耐药性；基因和反义疗法；病理学、标记物和预后目标；化学防备战略；多模态医治；和各类体例的整合。

《Clinical Lung Cancer》(临床肺癌)编辑部通信体例为CIG MEDIA GROUP, LP, 3500 MAPLE AVENUE, STE 750, DALLAS, USA, TX, 75219-3931。若是您须要辅佐投稿或润稿办事，您可以或许征询咱们的客服教员。咱们专一于期刊征询办事十年，熟习颁发政策，可为您供给一对一投稿指点，防止您在投稿时频仍碰鼻，节流您的可贵时候，有用晋升颁发机率，确保SCI检索（检索不了全额退款）。咱们视诺言为生命，多方面确保文章宁静失密，在任何环境下都不会泄漏您的小我信息或稿件内容。